Congo to use Ebola vaccine to counter flare-up

Four people have tested positive for Ebola


Democratic Republic of Congo (DRC) officials say they will start using Ebola vaccine to counter a flare-up in the heavily populated eastern part of the Central African country, according to an article on the Reuters website.

Four people have tested positive for Ebola in and around Mangina, a town of about 60,000 people in North Kivu province, about 60 miles) from the Ugandan border.  

Another 20 people died from unidentified hemorrhagic fevers in July. The World Health Organization (WHO) declared the ninth outbreak of Ebola in the Democratic Republic of the Congo (DRC) over on July 24, according to an article on WHO website. 

Unlike previous DRC Ebola outbreaks, this one involved four locations, including an urban center with river connections to the capital and to neighboring countries, as well as remote rainforest villages.

Read the article.

 

 



August 7, 2018


Topic Area: Infection Control


Recent Posts

The Role of Biophilic Design in Healthcare Facilities

Nature-inspired design can support staff well-being and create more welcoming, human-centered healthcare environments.


TriStar Centennial Medical Center Invests $90M in Women, Children's Hospital Expansions

The multi-year project will bring significant improvements to both hospitals.


Virginia Cancer Specialists to Open Newly Expanded Fauquier Location

The new Fauquier location will serve as a hub for clinical research and innovation in the future.


Emergency Preparedness: Building a Stronger Community

Professional memberships offer a convenient way to access practical resources, stay current on critical changes and learn from peers.


Ground Broken on Lavine Bekenstein Cancer Hospital in Massachusetts

The 450,000-square-foot facility will feature 300 inpatient beds across ten floors and has been designed specifically around the needs of people with cancer and their families.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.